Latvia vs Mexico: Avoidable mortality
Avoidable mortality over time
- Latvia
- Mexico
How they compare
Mexico currently reports 373,220 Deaths against 8,179 Deaths in Latvia, a difference of 365,041 Deaths.
That makes Mexico's figure about 45.6 times Latvia's.
Across all 24 years both countries report, Mexico has been ahead every year.
Latvia ranks 5th and Mexico ranks 3rd of 7 countries.
Mexico has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14,392 Deaths | 251,650 Deaths | 237,258 Deaths | Mexico |
| 2010s | 10,152 Deaths | 310,586 Deaths | 300,435 Deaths | Mexico |
| 2020s | 9,799 Deaths | 493,299 Deaths | 483,500 Deaths | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Latvia or Mexico?
- Mexico, at 373,220 Deaths against 8,179 Deaths in Latvia as of 2023.
- What is the difference in avoidable mortality between Latvia and Mexico?
- 365,041 Deaths, with Mexico ahead.
- How many years of comparable data are there for Latvia and Mexico?
- 24 years are reported by both, from 2000 to 2023.
- How do Latvia and Mexico rank globally for avoidable mortality?
- Latvia ranks 5th and Mexico ranks 3rd of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.